Sippican Capital Advisors Abbott Laboratories Transaction History

Sippican Capital Advisors

$130 Million
Q3 2024

A detailed history of Sippican Capital Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Sippican Capital Advisors holds 3,590 shares of ABT stock, worth $424,086. This represents 0.31% of its overall portfolio holdings.

Number of Shares

3,590

Previous 3,690 2.71%

Holding current value

$424,086

Previous $383,000 6.79%

% of portfolio

0.31%

Previous 0.33%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$100.07 - $118.13 $10,007 - $11,813	-100 Reduced 2.71%	3,590 $409,000
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $32,737 - $36,543	-325 Reduced 8.09%	3,690 $383,000
Q1 2024 May 02, 2024	SELL	$109.52 - $120.96 $169,756 - $187,488	-1,550 Reduced 27.85%	4,015 $456,000
Q4 2023 Jan 30, 2024	BUY	$90.19 - $110.4 $45,095 - $55,200	500 Added 9.87%	5,565 $612,000
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $47,287 - $56,736	-495 Reduced 8.9%	5,065 $490,000
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $7,558 - $8,421	-75 Reduced 1.33%	5,560 $606,000
Q1 2023 Jul 14, 2023	SELL	$96.86 - $114.01 $10,170 - $11,971	-105 Reduced 1.83%	5,635 $570,000
Q4 2022 Jan 26, 2023	BUY	$95.06 - $111.52 $3,802 - $4,460	40 Added 0.7%	5,740 $0
Q3 2022 Oct 17, 2022	SELL	$96.76 - $112.03 $2,419 - $2,800	-25 Reduced 0.44%	5,700 $552,000
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $228 - $278	-2 Reduced 0.03%	5,725 $678,000
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $103,977 - $127,314	-900 Reduced 13.58%	5,727 $806,000
Q3 2021 Oct 20, 2021	SELL	$116.66 - $129.06 $40,831 - $45,171	-350 Reduced 5.02%	6,627 $783,000
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $8,707 - $10,258	-80 Reduced 1.13%	6,977 $836,000
Q4 2020 Jan 21, 2021	SELL	$105.0 - $114.42 $71,085 - $77,462	-677 Reduced 8.75%	7,057 $773,000
Q3 2020 Oct 23, 2020	BUY	$91.64 - $111.29 $15,303 - $18,585	167 Added 2.21%	7,734 $842,000
Q2 2020 Jul 15, 2020	SELL	$76.57 - $98.0 $10,336 - $13,230	-135 Reduced 1.75%	7,567 $692,000
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $14,448 - $21,127	-230 Reduced 2.9%	7,702 $608,000
Q4 2019 Jan 21, 2020	SELL	$78.51 - $87.4 $1,570 - $1,748	-20 Reduced 0.25%	7,932 $689,000
Q3 2019 Oct 17, 2019	SELL	$81.84 - $88.74 $36,828 - $39,933	-450 Reduced 5.36%	7,952 $665,000
Q2 2019 Jul 17, 2019	SELL	$72.88 - $85.0 $32,285 - $37,655	-443 Reduced 5.01%	8,402 $707,000
Q1 2019 Apr 17, 2019	SELL	$66.22 - $80.06 $15,826 - $19,134	-239 Reduced 2.63%	8,845 $707,000
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $1,216 - $1,467	-20 Reduced 0.22%	9,084 $663,000
Q2 2018 Jul 17, 2018	SELL	$57.57 - $63.54 $63,039 - $69,576	-1,095 Reduced 10.74%	9,104 $555,000
Q1 2018 Apr 24, 2018	SELL	$56.27 - $63.62 $11,254 - $12,724	-200 Reduced 1.92%	10,199 $611,000
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $499,775 - $557,802	10,399	10,399 $555,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Sippican Capital Advisors with notifications on news.

Account

Sippican Capital Advisors Abbott Laboratories Transaction History